Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
TIlray Brands, Inc. (TLRY) generates frequent news as a global lifestyle and consumer packaged goods company active across cannabis, beverage, wellness, and entertainment categories. Company updates often highlight developments in its cannabis brands, medical cannabis operations, beverage portfolio, and strategic corporate actions, giving investors and followers insight into how Tilray is executing its multi-category strategy.
News coverage commonly includes financial results and segment performance across cannabis, beverage, wellness, and distribution, as reflected in Tilray’s quarterly earnings releases. These updates may discuss trends in international medical cannabis revenue, Canadian adult-use cannabis sales, and distribution activity through Tilray Pharma. Corporate announcements, such as the implementation of a one-for-ten reverse stock split and related shareholder decisions, are also reported through press releases and SEC filings.
Tilray’s brand and product news provides detail on new launches and category expansion. Recent communications feature Dry January and holiday guides showcasing hemp-derived THC beverages, zero-proof spirits, non-alcoholic beers, and craft beers, as well as cannabis-infused beverages under brands like Mollo and XMG. Other releases focus on innovations in cannabis vapes and concentrates under brands such as Good Supply and Redecan, and curated cannabis gift guides that reflect consumer trends in Canada.
Regulatory and medical developments are another important theme. Tilray Medical has issued statements on U.S. federal cannabis rescheduling and the creation of Tilray Medical USA, outlining a framework for U.S. medical cannabis expansion based on experience in regulated international markets. For readers tracking TLRY, this news stream offers context on how the company responds to policy changes, evolves its brand portfolio, and communicates with shareholders. Bookmark this page to access an organized feed of Tilray’s earnings releases, product announcements, regulatory updates, and other material company news.
Breckenridge Distillery (NASDAQ: TLRY) appointed Romano Beverage to manage statewide distribution in Illinois, covering its full spirits lineup including bourbon, whiskey, rum, vodka, gin, and the new Mountain Shot.
Romano will use its Elmhurst facility and local salesforce to provide logistics, retail activation, and on-premise support to expand Breckenridge's presence across Illinois.
Tilray (NASDAQ: TLRY) announced that CC Pharma, its European pharmaceutical distribution business, was named a TOP 100 Innovator in Germany on Feb 4, 2026. CC Pharma serves over 13,000 pharmacies nationwide and supports medical cannabis distribution using established infrastructure and regulatory expertise.
The award recognizes innovation management, forward-looking strategy, and sustainable competitiveness, and highlights CC Pharma’s regional footprint, digitalization efforts, and employer attractiveness within Germany’s healthcare supply chain.
Tilray Brands (NASDAQ: TLRY) is staging nationwide tap room promotions for Sunday, February 8, 2026, across its craft beer and distillery locations.
Participating brands include SweetWater, Montauk, Breckenridge, Blue Point, 10 Barrel, Hop Valley, Terrapin, and Atwater, offering game-day food, drink deals, extended hours, raffles, and to-go bundles with some preorder deadlines.
Terrapin Beer Co. (NASDAQ: TLRY) announced a comprehensive brand refresh on January 29, 2026, updating logos, packaging, point-of-sale, merchandise and digital touchpoints.
The redesign features artist collaborations, album-inspired artwork, a modernized logo and a new slogan, "Terrapin Beer. Sounds good." Rollout begins this month with wider retail availability over several months.
Tilray Brands (NASDAQ: TLRY) announced the lineup and ticketing for SweetWater 420 Fest, returning April 17-18, 2026 at Shirley Clarke Franklin Park in Atlanta.
The 21st annual festival will feature headliners Umphrey’s McGee (April 17), Thievery Corporation (April 18) and Chromeo (April 18), plus supporting acts including Cimafunk, Watchhouse, The Moss, lespecial, Sneezy, Bombargo and others.
Tickets start at $40 for single-day GA, $70 for two-day GA, single-day VIP at $105 and two-day VIP at $200. The festival emphasizes a new park venue with 280+ acres and more affordable pricing.
SweetWater (NASDAQ: TLRY) launched Big Trip Double IPA on January 22, 2026, a high-ABV extension of its Daytrip IPA line. The beer features a 9% ABV profile with bright citrus and tropical aromas from Mosaic, Idaho 7, Sultana, Citra and El Dorado hops and a grain bill of 2-row, Pilsner and Wheat.
Big Trip is available in 19.2 oz tall singles and 6-pack 12 oz cans, rolling out nationwide through taprooms, liquor stores, groceries and convenience stores, with tall singles and six-packs representing 80% of high-ABV sales in the Southeast.
Tilray Medical (Nasdaq: TLRY) on Jan 22, 2026 launched Tilray Medical Italia, the rebranded entity previously known as FL Group, to unify and scale its medical cannabis platform in Italy. The move includes a partnership with Molteni Farmaceutici and distribution through hospital and pharmacy channels under authorization from the Italian Ministry of Health. Products are EU‑GMP certified and available by prescription, spanning cannabis flowers (THC 25%, 18%, 9%/CBD 9%) and multiple THC:CBD oil formulations. The launch aligns with Tilray Medical’s pan‑European strategy and regulatory-focused growth approach.
Tilray Brands (Nasdaq: TLRY) reported a record Q2 fiscal 2026 with net revenue of $217.5M ($218M rounded), driven by a 36% increase in international cannabis and a 6% rise in Canadian adult‑use cannabis. Distribution (including Tilray Pharma) hit a quarterly high of $85.3M. Gross profit was $57.5M and adjusted EBITDA was $8.4M. The company improved its net loss to $(43.5)M and reported $291.6M in cash and marketable securities, moving to a net cash position of $27.4M. Tilray reaffirmed full‑year adjusted EBITDA guidance of $62M–$72M.
Tilray Brands (Nasdaq: TLRY) launched a Dry January product collection on Jan 6, 2026 that includes hemp-derived Delta-9 THC sparkling cocktails and seltzers, premium zero-proof spirits, and multiple non-alcoholic craft beers.
Key SKUs include Happy Flower sparkling THC cocktails, Fizzy Jane’s THC seltzers, Mock One zero-proof spirits, Runner’s High non-alc beer, Montauk Brewing non-alc IPA and Golden, and 10 Barrel NA Apocalypse IPA. Products are available online and at select retailers nationwide.
Tilray (Nasdaq: TLRY) launched Mollo and XMG cannabis beverages for Dry January, promoting alcohol-free options with consistent cannabinoid profiles and bold flavours.
New Mollo four-packs include Blackberry and Wild Berry Açaí (each can: 10 mg THC / 20 mg CBG); Mollo classics and Orchard Chill’r carry 10 mg THC / 10 mg CBG. XMG line includes flavored sodas, zero-sugar variants, and Atomic Sours, most cans featuring 10 mg THC (many also 10 mg CBG) and select SKUs with guarana.
The release cites the non-alcoholic beverage market up 24% YoY to $199M and notes products are available nationwide in Canada at select retailers, subject to provincial rules.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
